and fourth with was and XXXX full plan. Thank EMEA you, Latin America. through North in conditions the and much Asia had quarter X.
Market can one everyone. found our on our quarter. performing Zack, on results Slides exception behavior as year we buyer were expected to be good morning, fourth Details pretty X and America, The
correction, impacted are were sales in market somewhat all negatively In to X%, continued more drought diamide which and conditions. or products, resilience offset up the in flat ongoing channel Branded This in addition despite the quarter conditions higher our was differentiated by showing stronger of Brazil. results sales our regions. by with were essentially sales
the expecting in running correction total While last our inventory first X overall this outperformed and channel at revenue. products XXXX. the years its continue the is portfolio comprised through of to we're XX% regions, The and rates through the course launched varying of half
input business our However, protection products the industry third-party at solid. own underlying steady continue fundamentals applied and rates. of Based remains commercial on teams, from this be our crop in to data
in level, XX% a a sales in record quarter Star XX%, America, year, Premio essentially sales Looking XX% revenue prior and decline. the lower the due as prior from lower volume was versus low regional were pricing excluding QX were on XXXX. diamides Latin Branded down by at launch Brazil. fourth year successful volumes double-digit flat aided America North down expected after to FX, to of In
lower with herbicides. year in offset addition, inventory mostly sales lower of fungicides to sales Revenue quarter were in particularly higher excluding Fourth Mexico year sales In growth diamide had in EBITDA. Fourth sales. products. to flat tailwind lower biologicals and in effectively Costs in and Presticor R&D. the elevated.
Branded of in supported effectively as results more Branded launches contributions solid XX% EMEA quarter and a growth period. in and Verimark we were than or new strong to from XX%, by region volume, remains in SG&A region spending continued of prior benefit primarily Asia as was by [ destocking, period inventory channel costs implement a line strong to FX, driven lower prior with initiatives. lower to Price down low XX% the the prior in year experienced period price XX% was diamide Turkey.
Shifting ] the in the in were due where mid-single-digit Spain input than to sales India, due diligent were both controlled
levels. in XXXX full in substantial of of approximately margin digits decline EBITDA our Slide was of EMEA, XXX results in billion, double $XX raising by year. year Our favorability basis million decline for X. or at full accomplished than year a offset low points XXXX effective in lower benefited the second from took in by remains holding actions to cost delivered spend well through which sales lower by more a the we price We had the demand, nearly $X.X increase about for XX%. many $XX price spend cost management geographies, sales are excess industry-leading XX% the year especially on This of was but and listed in the response target. half were volume.
Operating reductions Diamide was million of that to for
demand total our XXXX. outperformed down and record, portfolio, X% up new made over little down X%.
Across NPI only of were diamides the branded XX% new revenue. up much sales products resilience and annual our were in of a innovative a our even a sales and greater environment. from showed only XX% weak more However, in
our stone in such soy, drove that Star ingredient, include Premio for for number and products fungicide insecticide Brazil, this and active products soy, Full and based as New Onsuva for performance sugarcane Boral fluindapyr. of herbicides a on new soy,
Evo of for Altacor herbicides themselves for Overwatch benefited cereals. and for vegetables canola, fruits insecticide and also insecticide Coragen We MaX
inventory inventory we're would channel in we systems proprietary track and time their the the visibility into utilizing we and move real-time also to to especially which the highlight gain including distributors our place distributor have and give XXXX, as in some we taken our into enhance Europe, real discussion across surveys products. of like important of of the Before final to covering put Mexico, Asia, In most visibility will to hundreds have stages to of then in India, movement In sellout. actions our to X countries I passes us to growers insight and of inventory. larger integrating the with retailers, of our channel retailer grower. it in from countries, of digital those platforms inventory are In
will our distributors now piloting the include finally, forecasting system. the are increased and are In demand also in tracking retailers. updates Brazil. our beyond forecasting And set be the This into incorporated expanded inventory Argentina, expanding processes. have U.S., We to same of approach in system frequency to process data we we then our data
expectations. XXXX to Moving
full now XX. and XXXX billion point on and revenue Having Our established Slide billion, XXXX, we commentary year $X.X provided to guidance an starting midpoint. $X.X of of for expect being increase X.X% X the a through at closed
single monsoons.
Revenue in be full million is by led for from Brazil this insecticide to of Brazil, due products growth market growth inventory softer to India, is $XXX in XXXX. growth down channel We and centers the NPI, of insecticide FMC low multiple of exception the come global of Argentina. resumption and launched single-digit we of unfavorable in full in the NPI half. entire as posting to growth in down Premio Almost by low as is $XXX which U.S. seasons approximately XXXX, digits sales market to by expected higher half year in the result flat Argentina first in after million XXXX. Overwatch to is include forecast NPI that the XXXX to Star Australia expected second volume percent historical to expect The where grow the are as anticipating half for products a in be followed well the a carrying industry in sales driving the expect to primarily Major as Coragen fungicide year, we be eVo Onsuva on herbicide
that, due reflects year pressure reduced to year.
EBITDA our benefits from $XXX although challenges between midpoint. is the the Adjusted flat pressure. operations The and than expected share the than million gross $XXX for fixed earnings $XXX range outlook increase be be and midpoint second pricing range had in mainly XXXX. expect $X.XX $X.XX XXXX were additional our the in modest marketplace. impact from headwinds share, revenue absorption D&A.
At expected midpoint for be half. year, FX preliminary the actual to higher Broader to is our the expected Investor and the midpoint an carried aggressively of cost forward largest XXXX offset of EBITDA November Day, Growth We acknowledge in and moderate of preliminary first expected and business to products to interest from to billion, XXXX is at in with X% results. $X.XX expectation realities be to to expense at per to the million at our and million our updated outlook, minor November. now we current the the needed responded This sales minor headwind by margin. the new also low is presented between a pricing inventory the is better align of restructuring lower The are half prior actions with per market lower cost lower in FMC range
a and we how as and global actions transform are QX. program restructuring will including Brazil XXXX be changes the provides underway model, as costs quickly We we plan This restructure where operating is position focuses structural and will largely on the a in expenses multipronged shorter-term These model. the will currently approach structural we completed on for X the that taking. XXXX and operate The that of work. goals.
Slide beyond fundamentally towards way operating end moving our by detail move global organized, our we're some restructuring on additional is we're we success longer-term
actions our U.S. to will We voluntary approximately through Combined, reductions additional strong sourcing Solutions for with including critical sell have nonessential we've business. company-wide. made separation our implementing impacted team Reducing to indirect on spend in areas, as X% consolidate strategy.
We begin announced preparations already roles strategic we of the our a also spend progress Global be workforce place and program structures. plans another many adjust workforce where Specialty noncrop and a is accelerated new
last are ready now regional we footprint. to preparing We and the and this we global months, company's marketing.
And begin over the are examining will X for lastly, be
made and critical so FMC's pillar a and research examining in office analysis in locations, strategy manufacturing Our centers. far. This we've overall progress includes is transformation, good location our sites
we Although this be there work will will is that this year. stream, throughout announce longer-term milestones a
net million for we that the important these plan reminder, savings to and year. that $XX cost to in of headwinds note inflationary a forecasting $XX in are we're As savings to million expect other result this of XXXX. restructuring It's cost
and that deliver million to some growers with of We R&D, costs the innovation.
Slide XXXX. plant of determinant expect of factors areas varying plan $XXX XX in as new factor. growth and outcomes while complete by the restructuring including of lists would continuing in lower critical our guidance EBITDA still to range. savings end in such lead The engagement recovery the is further run this product investments We business, to largest prioritize our health market rate pace the
Our period, and XX% lower to market base inventory the plan see forward year.
Slide quarter million billion sales achieve smaller for with manage by is between full growth than aided XXXX.
Taking but with to we Expected pricing cost secondary will Volume is by half assumption provides XX account of revenue the lower a guidance decline XX full the application and driven consistent inventory Slide $XXX year $XXX sales overall midyear, is the million declines as to lower our quarter than to first for for the X how into year the from versus mix. year guidance bridge higher prior steady provides have region of first driver the primary of midpoint, every at the to track lower carried had pressure primarily the prior quarter. the second that well quarters. which component only conditions, region, by prior million by last expect revenue may Asia, of is of in of sales be vary by that guidance higher higher outlook remaining as which desired growers. year $XXX The will over over America have products. volume one expected is record impact the market the the EBITDA Not but is is a by a growth of these contribute second Recovery the new $X.XXX levels, Latin rates products to margins, quarter EBITDA in do period in delivering growing headwind. also quarters. sales with strong difficult they we to largest season positively fourth our
in the the in year half by as majority program, to occurring $XXX expect implemented. benefits growth contribute through restructuring of XXXX million We sales the the EBITDA recovery QX. growth. over grow from also second as our NPI to which are build initiatives Market well after with we'll will
you built now our on plan control an As to upon a call guidance. see, can With the turn not we we that, recovery and reliant to Andrew. are achieve based primarily have I'll outsized market over elements
